Safety of Uninterrupted Periprocedural Edoxaban Versus Phenprocoumon for Patients Undergoing Left Atrial Catheter Ablation Procedures

This study sought to compare safety of uninterrupted edoxaban with uninterrupted phenprocoumon administration during LA RF ablation for atrial fibrillation (AF) and atrial tachycardia (AT). In total, 231 patients (mean age: 64 +/- 11years, male 71%) who underwent LA RF ablation under continuous oral anticoagulation (OAC) with edoxaban or phenprocoumon were included in the study.

Source: The American Journal of Cardiology - November 23, 2017 Category: Cardiology Authors: Marc Kottmaier, Felix Bourier, Hannah Pausch, Tilko Reents, Verena Semmler, Martha Telishevska, Katharina Koch-B üttner, Carsten Lennerz, Sarah Lengauer, Marielouise Kornmayer, Elena Rousseva, Stephanie Brooks, Amir Brkic, Sonia Ammar-Busch, Bernhard Kae Source Type: research